KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic): 2015-2025

Historic EPS (Basic) for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $3.95.

  • Medpace Holdings' EPS (Basic) rose 27.01% to $3.95 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.66, marking a year-over-year increase of 23.92%. This contributed to the annual value of $13.06 for FY2024, which is 41.96% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' EPS (Basic) is $3.95, which was up 25.00% from $3.16 recorded in Q2 2025.
  • Medpace Holdings' 5-year EPS (Basic) high stood at $3.95 for Q3 2025, and its period low was $1.11 during Q2 2021.
  • Moreover, its 3-year median value for EPS (Basic) was $3.11 (2024), whereas its average is $3.01.
  • Over the last 5 years, Medpace Holdings' EPS (Basic) had its largest YoY gain of 63.24% in 2021, and its largest YoY loss of 2.80% in 2021.
  • Medpace Holdings' EPS (Basic) (Quarterly) stood at $1.39 in 2021, then soared by 56.83% to $2.18 in 2022, then grew by 16.97% to $2.55 in 2023, then soared by 48.24% to $3.78 in 2024, then climbed by 27.01% to $3.95 in 2025.
  • Its last three reported values are $3.95 in Q3 2025, $3.16 for Q2 2025, and $3.77 during Q1 2025.